Cervical cancer screening programmes and policies in 18 European countries

被引:0
作者
A Anttila
G Ronco
G Clifford
F Bray
M Hakama
M Arbyn
E Weiderpass
机构
[1] The Finnish Cancer Registry,Department of Medical Epidemiology and Biostatistics
[2] Unit of Cancer Epidemiology,undefined
[3] CPO Piemonte,undefined
[4] The International Agency for Research on Cancer,undefined
[5] Scientific Institute of Public Health,undefined
[6] Cancer Registry of Norway,undefined
[7] Karolinska Institutet,undefined
来源
British Journal of Cancer | 2004年 / 91卷
关键词
epidemiology; cervix uteri; screening; evaluation; monitoring;
D O I
暂无
中图分类号
学科分类号
摘要
A questionnaire survey was conducted by the Epidemiology Working Group of the European Cervical Cancer Screening Network, and the International Agency for Research on Cancer, IARC, between August and December 2003 in 35 centres in 20 European countries with reliable cervical cancer incidence and/or mortality data in databanks held at IARC and WHO. The questionnaire was completed by 28 centres from 20 countries. The final tables included information on 25 centres from 18 countries. Six countries had started screening in the 1960s, whereas 10 countries or regions had started at least a pilot programme by 2003. There were six invitational and nine partially invitational programmes, the rest employing opportunistic screening only. Recommended lifetime number of smears varied from seven to more than 50. Coverage of smear test within the recommended screening interval (usually 3 or 5 years) was above 80% in three countries. Screening registration took place in 13 programmes. Eight programmes reported the rates of screen-detected cervical cancers and precursor lesions. There was wide variation in the CIN3 detection rates. International guidelines and quality assurance protocols are useful for monitoring and evaluating screening programmes systematically. Our survey indicated that the recommendations as currently given are met in only few European countries. Health authorities need to consider stronger measures and incentives than those laid out in the current set of recommendations.
引用
收藏
页码:935 / 941
页数:6
相关论文
共 87 条
[1]  
Anderson GH(1988)Organisation and results of the cervical cytology screening programme in British Columbia, 1955–1985 Br Med J (Clin Res Ed) 296 975-978
[2]  
Boyes DA(2002)Trend of cervical cancer mortality in Belgium (1954–1994): tentative solution for the certification problem of unspecified uterine cancer Int J Cancer 102 649-654
[3]  
Benedet JL(1995)PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal pap smear J Clin Epidemiol 48 1235-1243
[4]  
Le Riche JC(1994)Cervical cancer Cancer Surv 19–20 265-285
[5]  
Matisic JP(2002)Estimates of cancer incidence and mortality in Europe in 1995 Eur J Cancer 38 99-166
[6]  
Suen KC(1993)European guidelines for quality assurance in cervical cancer screening Eur J Cancer 29A S1-S38
[7]  
Worth AJ(1968)Cervical cancer detection in British Columbia J Obstet Gynecol Br Commonw 75 392-404
[8]  
Millner A(1976)Effect of a mass screening program on the risk of cervical cancer Am J Epidemiol 103 512-517
[9]  
Bennett OM(2003)Women's experience of coping with a positive pap smear: a register-based study of women with two consecutive Pap smears reported as CIN 1 Acta Obstet Gynecol Scand 82 756-761
[10]  
Arbyn M(1987)Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes Lancet 1 1247-1249